On May 12, ZBD Pharmaceutical signed a series of strategic cooperation agreements with Shanghai University of Traditional Chinese Medicine, in which the two sides will carry out strategic cooperation in innovative drug development, in-hospital preparation development, secondary development of ZBD own varieties and talent support.
It is understood that the two sides will focus on improving and developing the whole industrial chain of TCM, give full play to their advantages, accurately grasp the development direction of TCM inheritance and innovation, and carry out comprehensive strategic cooperation in the fields of "production, learning, research and application". We will work together to promote the inheritance, innovation and development of TCM and help build a "Healthy China".
In Shanghai University of Chinese Medicine, Chairman Fang Tonghua and his delegation first visited the Museum of Shanghai University of Chinese Medicine and other venues, systematically reviewed the history and essence of the development of traditional Chinese medicine, and had a detailed understanding of the development and construction of Shanghai University of Chinese Medicine.
At the signing ceremony, Chen Hongzhuan, vice president of Shanghai University of Chinese Medicine, first delivered a speech. Chen Hongzhuan said that the signing was the first time for the secondary college to establish a cooperative relationship with an enterprise, which would also be a new beginning for the school-enterprise cooperation of Shanghai University of Chinese Medicine. Shanghai University of Traditional Chinese Medicine (SCUM) is one of the first TCM institutions of higher learning established by the People's Republic of China after the founding of the People's Republic of China. Over the years, SCUM has shoulded the responsibility of deepening the reform of TCM higher education, promoting independent innovation of TCM, and leading the development of TCM in China. The cooperation in talent construction and scientific research is complementary to the advantages of both sides. We hope that both sides can make contributions to the development of TCM, talent training and scientific innovation.
Later, Chairman Fang Tonghua said in his speech that ZBD is a modern, large-scale and platFORM-based enterprise group based on traditional Chinese medicine and featuring the big health industry. Reviewing the construction and development of ZBD, the enterprise has established a multi-dimensional strategic partnership with Shanghai University of Traditional Chinese Medicine. At the important moment when ZBD is fully promoting scientific and technological innovation and industrial upgrading, Shanghai University of Traditional Chinese Medicine brings new cooperation opportunities, innovation platforms and talent support to enterprises! We will take this contract as an opportunity to push our strategic cooperation to a new height.
Zhang Weidong, president of the Institute of Interdisciplinary Sciences, said in his speech that ZBD Pharmaceutical Co., Ltd. 's commitment and enthusiasm for scientific research in the industry are well known to all. With the sincere cooperation of both parties, I believe that during the 14th Five-Year Plan period in the future, we will be able to complete the research and development of several innovative drugs with independent intellectual property rights and jointly establish a new platform for the completion of smart Chinese medicine. We believe that in the next five years, we will achieve even more outstanding results. Finally, in the warm applause, both sides of the school and enterprise completed the signing ceremony.
It is understood that in this cooperation, Shanghai University of Traditional Chinese Medicine will focus on the market and the advanced TCM treatment field promoted by ZBD, and carry out research on the quality standard, mechanism of action, scientific connotation and secondary development of innovative TCM drugs, in-hospital preparations and ZBD own varieties. In addition, we have carried out extensive, in-depth and long-term cooperation with ZBD Pharmaceutical Co., Ltd. on the project contents of discovery and development of innovative medicines from traditional Chinese medicine sources, joint development of traditional Chinese medicine components, secondary development of dominant varieties, and assistance in the evaluation and development of preparations in the hospital.
At the same time, ZBD Chair Professor and ZBD Young Scholar Talent Support Program will be set up to further encourage outstanding scientific research talents, promote the development of innovative drugs, and realize the efficient combination of production, education and research. In the end, it will definitely promote the enrichment and upgrading of the product pipeline of ZBD, enhance the core technological innovation and talent competitiveness, and help ZBD Pharmaceutical to develop towards the direction of international innovative enterprise group with top research and development ability.